Huntington's disease (HD) is one of main neurodegenerative diseases, characterized by
striatal atrophy, involuntary movements, and motor incoordination. Ginsenoside Rg1 (Rg1) …

Ginsenoside Rg1 is one of the most active ingredients in ginseng, which has been reported
to protect dopaminergic neurons and improve behavioral defects in MPTP model, 6-OHDA …

Background Huntington's disease (HD) is a neurodegenerative disorder caused by the
expansion of trinucleotide CAG repeat in the Huntingtin (Htt) gene. The major pathogenic …

Aim: To investigate the effect of ginsenoside Rg1, an effective ingredient from ginsenoside,
on 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐induced substantia nigra …

Aims: Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of
dopaminergic neurons in the substantia nigra (SN) and diminished dopamine levels in the …

Abstract Ginsenoside Re (G‑Re) is a panaxatriol saponin and one of the pharmacologically
active natural constituents of ginseng (Panax ginseng CA Meyer). G‑Re has antioxidant, anti …

Abstract Aims Glycyrrhizin (Glyc) is a saponin triterpenoid that has signified its efficacy
against Huntington's disease (HD). Nonetheless, its mechanism has not been fully clarified …

Abstract Ginsenoside Rg1 (Rg1) is a major bioactive ingredient in Panax ginseng that has
low toxicity and has been shown to have neuroprotective effects. The objectives of the …

Abstract Gintonin (GT), a ginseng-derived lysophosphatidic acid receptor ligand, regulates
various cellular effects and represses inflammation. However, little is known about the …

Ginsenoside Rb1 has been demonstrated to protect dopaminergic (DA) neurons from death
in vitro. However, the neuroprotective effects and underlying mechanism of Rb1 in treating …